Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (221-230 of 401) with videos related to

Pageof 41
Sort By:
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)Vijay Kunadian, Stefan K James, Daniel M Wojdyla, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Emergency Medicine Journal : EMJ|June 10, 2024
Clinical decision aids and computed tomography coronary angiography in patients with suspected acute coronary syndromeKang-Ling Wang, Caelan Taggart, Michael McDermott, et al.
Journal of the American Heart Association|May 6, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 TrialBaris Gencer, Xinmin S Li, Yared Gurmu, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
Arrhythmia & Electrophysiology Review|December 25, 2025
Long-term Survival and Stroke after Cardiac Surgery with Concomitant Surgical Ablation for Atrial FibrillationMark A Sammut, Justin Lee, Sxe Chang Cheong, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
Pageof 41

Showing results (221-230 of 401) with videos related to

Sort By:
Pageof 41
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)Vijay Kunadian, Stefan K James, Daniel M Wojdyla, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Emergency Medicine Journal : EMJ|June 10, 2024
Clinical decision aids and computed tomography coronary angiography in patients with suspected acute coronary syndromeKang-Ling Wang, Caelan Taggart, Michael McDermott, et al.
Journal of the American Heart Association|May 6, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 TrialBaris Gencer, Xinmin S Li, Yared Gurmu, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
Arrhythmia & Electrophysiology Review|December 25, 2025
Long-term Survival and Stroke after Cardiac Surgery with Concomitant Surgical Ablation for Atrial FibrillationMark A Sammut, Justin Lee, Sxe Chang Cheong, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
Pageof 41